These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 396983)

  • 1. [Ischaemic heart disease risk factor correlation in patients after myocardial infarction (author's transl)].
    Blazej V; Závada M; Müller J; Vykopal V; Artner P; Zurková M; Vanĕk J
    Cas Lek Cesk; 1979 Dec; 118(52):1620-4. PubMed ID: 396983
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoreactive insulin in obese patients with coronary atherosclerosis and myocardial infarct (author's transl)].
    Karlícek V; Topolcan O; Chudácek Z
    Cas Lek Cesk; 1976 Feb; 115(7):207-9. PubMed ID: 1260822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the share of phosphatidylcholine in total phospholipid concentration in patients with ischaemic heart disease and after myocardial infarction (author's transl)].
    Votruba M; Schmidtová H; Rouchal J; Vacková V
    Cas Lek Cesk; 1981 Jul; 120(27):823-5. PubMed ID: 7261003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood lipids and myocardial infarct. Correlation between lipoprotein patterns and coronary heart disease confirmed].
    Schwandt P
    MMW Munch Med Wochenschr; 1984 Feb; 126(8):185-6. PubMed ID: 6425656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lipoprotein (a) in coronary heart disease and myocardial infarction].
    Wottawa A; Fromme K; Klein G
    MMW Munch Med Wochenschr; 1984 Jan; 126(3):53-5. PubMed ID: 6230531
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperlipoproteinemia (Frederickson's classification) in patients with myocardial infarction and imminent infarction].
    Kedra M; Poleszak J; Rymar B
    Pol Tyg Lek; 1975 Jun; 30(22):945-7. PubMed ID: 1135069
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood lipid levels as indicators of risk in the epidemiology of ischaemic heart disease (author's transl)].
    Pokorný J; Jezková Z
    Sb Lek; 1974 Jan; 76(1):1-7. PubMed ID: 4842894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients].
    Orbetsov G; Orbetsova V; Dakovska L
    Vutr Boles; 1984; 23(5):100-6. PubMed ID: 6523839
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alpha cholesterol in ischemic heart disease and myocardial infarct].
    Orbetsov M; Petrova V; Stankusheva G; Tsolov S
    Vutr Boles; 1981; 20(6):68-71. PubMed ID: 7336708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The lipoproteic state in patients with coronary heart disease (author's transl)].
    Catalano M; Carzaniga G; Garimoldi M; Sala R; Castelfranco M; Libretti A
    G Ital Cardiol; 1981; 11(12):1944-7. PubMed ID: 7346295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dyslipidemia as a risk factor in atherogenesis].
    Panaitescu G; Fica V; Stănescu L; Serban M; Roşca L; Enache M
    Med Interna (Bucur); 1972 Apr; 24(4):423-40. PubMed ID: 5027788
    [No Abstract]   [Full Text] [Related]  

  • 12. [The lipid disorders in the blood serum in men with myocardial infarction and coronary diseases aged less than 45 years (author's transl)].
    Gregorczyk J; Torbus-Lisiecka B; Olszewska M; Chomicz J; Wesołowska T; Bobnis W; Klimek K; Szmatłoch E
    Przegl Lek; 1978; 35(4-5):421-2. PubMed ID: 693983
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunoreactive insulin in acute infarction of the myocardium (author's transl)].
    Karlícek V; Topolcan O
    Cas Lek Cesk; 1976 Apr; 115(14):426-8. PubMed ID: 1268890
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum magnesium, serum cholesterol and serum lipoproteins in cases of coronary artery disease.
    Bordia A; Sharma SK; Mathur A; Sanghvi LM
    Indian Heart J; 1972 Jul; 24(3):277-81. PubMed ID: 4348910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipoproteins and coronary cardiopathy].
    Angelino PF; Abrate M; Pizzuti A; Bernardi FR; Bulgarelli GC; Aillon C; Passarino G; Carta Q; Della Beffa V
    Minerva Cardioangiol; 1981 Apr; 29(4):163-7. PubMed ID: 7242947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin secretion and glycide metabolism after myocardial infarction (author's transl)].
    Kimlová I; Málková J; Bartos V; Vísek V; Slouka V
    Cas Lek Cesk; 1979 Nov; 118(45):1391-4. PubMed ID: 394843
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prospective study of the cardiovascular risk of patients with sudden deafness].
    Preyer S; Schmidt K; Wallroth L; Matthias R
    HNO; 1992 Mar; 40(3):79-85. PubMed ID: 1577629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins--important discriminators for atherosclerotic vascular disease.
    Mordasini R; Riesen WF
    Monogr Atheroscler; 1986; 14():145-9. PubMed ID: 3736553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipoprotein Lp(a): a risk factor for atherosclerosis].
    Gutiérrez Fuentes JA; Gutiérrez Yago JJ; Díez Monedero E; Alvarez Berceruelo J; Zamorano Curiel P; Tejerina Abanades L
    Med Clin (Barc); 1989 Nov; 93(15):565-7. PubMed ID: 2533645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperlipoproteinemia in patients hospitalized for ischemic coronary disease and myocardial infarct].
    Cisarik F; Gavalec M; Zánová J; Hrbánová Z
    Vnitr Lek; 1981 Feb; 27(2):137-41. PubMed ID: 7467156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.